Urine Trouble? Opportunities to Improve Urine-Based Diagnostics for Infectious Diseases
Tracking # 20-1241238
Price not reported
There are no ratings for this course
Learn moreCourse overview
Recent advances in urine collection devices and diagnostic testing have provided opportunities for clinical laboratories to improve upon stagnant practices that may have deleterious effects on test utilization and result quality. Urine cultures are the gold standard for the diagnosis of urinary tract infection (UTI), one of the most common causes of bacterial infection, and therefore account for much of the workload in clinical microbiology laboratories. Contamination and workflow inefficiencies with urine specimens can lead to increased workload for the laboratory and antibiotic misuse in patients. Join Dr. Melanie L. Yarbrough to discuss the importance of pre-analytical variables in urine testing, describe the implementation and impact of reflex algorithms on urine culture utilization, and describe how laboratory-based initiatives to reduce unnecessary urine testing can improve workflow efficiency and impact patient care.
Subject areas
This course counts toward the state boards and subject areas below.
American Board of Clinical Chemistry
Clinical Chemistry Diplomate
Molecular Diagnostics Diplomate
Toxicological Chemistry Diplomate
Florida Board of Clinical Laboratory Personnel
Clinical Laboratory Director
Clinical Laboratory Supervisor
Clinical Laboratory Technician
Clinical Laboratory Technologist
Public Health Director
Public Health Supervisor
Public Health Technologist
Disclosure statements
The Association for Diagnostics & Laboratory Medicine (formerly AACC) is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.
The following faculty reported financial relationships:
Melanie Yarbrough, PhD, D(ABMM), D(ABCC)
- Honorarium/Expenses: bioMérieux, BD
- Grant/Research Support: bioMérieux, Pattern Bioscience, Beckman Coulter
- Board/Committee Membership/Advisory Board: Shionogi